Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1716241

registered interest
date	07/05/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, whether Captogan has been found in the UK; and whether his Department is taking steps to prevent it becoming available.
tabling member constituency	Rutland and Melton
tabling member printed	Alicia Kearns
uin	25086
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>In December 2021, the Government launched its ten-year drugs strategy, to cut crime and save lives<em>. </em>As part of this, £300 million has been allocated to fund activity to break drug supply chains from end-to-end, This includes restricting upstream flow, securing the UK border, and ensuring we remain agile in the face of changing threats.</p><p>The National Crime Agency (NCA) regularly assess the threat posed to the UK by the trafficking of illicit drugs. At this time, we are not aware of any captagon on UK streets and to date, no instances of captagon being seized at a UK border have been recorded; however, shipments have been seized in Europe.</p><p>As such, the UK will continue to seek coordinated global action to address the effects of the captagon trade, in close cooperation with our regional partners.</p><p>Beyond this, the UK Government and its law enforcement partners are leveraging our extensive international networks to maximise cooperation with other governments to tackle drug trafficking upstream. This includes identifying and disrupting organised crime groups aiming to exploit the UK, and seizing drugs before and during their journey to the UK.</p><p>Additionally, we are also funding Border Force and the NCA to develop and deliver innovative intelligence-led approaches to securing our border which keeps pace with changes to routes and methods used by criminals.</p> answering member constituency Croydon South answering member printed Chris Philp question first answered 14/05/2024 16:38:18 answering member 4503 label Biography information for Chris Philp
tabling member	4805 label Biography information for Alicia Kearns

1714163

registered interest
date	26/04/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what recent assessment he has made of the potential impact of overdose prevention units on drug users.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23900
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>No recent assessment has been made of the impact of drug consumption rooms, sometimes referred to as overdose prevention centres, on drug users.</p><p>The Government does not support drug consumption rooms. We have been clear that we have concerns about the potential for these facilities to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales.</p><p>While the Government remains open to considering any new evidence, the evidence available to date has informed the current policy position.</p> answering member constituency Croydon South answering member printed Chris Philp question first answered 07/05/2024 13:31:32 answering member 4503 label Biography information for Chris Philp
tabling member	4471 label Biography information for Rachael Maskell

1714164

registered interest
date	26/04/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, how he measuring is the level of synthetic drugs being (a) manufactured in the UK and (b) trafficked into the UK.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23901
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>Tackling illicit drugs, including potent synthetic opioids, is a priority for the Government and through our 10 year drugs strategy ‘From Harm to Hope’ we are taking action to tackle drug supply and reduce demand.</p><p>UK agencies are highly alert to the threat from synthetic drugs, including synthetic opioids like fentanyl and nitazenes, as well as synthetic cannabinoids and benzodiazepines. The Home Office, Department for Health and Social Care (DHSC), National Crime Agency (NCA), Border Force and the National Police Chiefs Council are working with local partners to proactively monitor and respond to synthetic opioid related deaths, tracking drug related deaths and other intelligence to ensure a quick response.</p><p>We assess that the scale of trafficking of synthetic opioids into the UK remains low. However, nitazenes, a type of synthetic opioid, have been linked to more than 100 deaths in the UK during the last year. The NCA assess that these substances are manufactured in illicit labs in China and have no evidence to suggest they are manufactured in the UK.</p><p>Through the cross-Government Synthetic Opioids Taskforce we are taking action and are working to enhance our drug harms surveillance and early warning system to provide monitoring information on the presence and impact of synthetic opioids or other drug threats to inform our response. It will also include data on lab-tested police seizures as well as state-of-the-art monitoring for the presence of synthetic drugs by analysing wastewater.</p> answering member constituency Croydon South answering member printed Chris Philp question first answered 07/05/2024 13:30:20 answering member 4503 label Biography information for Chris Philp
tabling member	4471 label Biography information for Rachael Maskell

1713942

registered interest
date	25/04/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what assessment he has made of trends in the levels of synthetic drugs in circulation.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23765
answer	answer is ministerial correction date of answer 02/05/2024 answer text <p>Tackling Class A drugs, including synthetic opioids, is a priority for the Government and through our 10 year drugs strategy ‘From Harm to Hope’ we are taking action to tackle drugs supply and reduce demand.</p><p>UK agencies are highly alert to the threat from synthetic drugs, including synthetic opioids like fentanyl and nitazenes, as well as synthetic cannabinoids and benzodiazepines. We assess that the scale of trafficking of synthetic opioids into the UK remains low. However, nitazenes, a type of synthetic opioid, have sadly been linked to more than 100 deaths in the UK during the last year, and we are taking action.</p><p>The cross-Government Synthetic Opioids Taskforce is working with partners, such as the NCA, the Department for Health and Social Care and the National Police Chiefs Council to deliver an evidence-based response to the risk posed by synthetic opioids, and to implement effective action to stem the demand and supply of these dangerous substances.</p> answering member constituency Croydon South answering member printed Chris Philp question first answered 02/05/2024 15:55:34 answering member 4503 label Biography information for Chris Philp
tabling member	4471 label Biography information for Rachael Maskell

1691176

registered interest
date	22/02/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, if he will make an assessment of the potential merits introducing drug contamination testing facilities in (a) England and (b) Romford constituency.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	15240
answer	answer is ministerial correction date of answer 29/02/2024 answer text <p>The Government has not made a formal assessment of the benefits of drug checking facilities, but it recognises the potential harm reduction benefits of them.</p><p>The Government facilitates drug checking facilities provided that the possession and supply of controlled drugs are licensed by the Home Office Drugs and Firearms Licensing Unit or, exceptionally, relevant exemptions under the Misuse of Drugs Regulations 2001 may apply.</p><p>Ministers are clear that drug checking services must not condone drug use and should only be delivered where licensed and operated responsibly, in line with Government policy to ensure that they discourage drug use and signpost potential users to treatment and support.</p> answering member constituency Croydon South answering member printed Chris Philp question first answered 29/02/2024 11:56:51 answering member 4503 label Biography information for Chris Philp
tabling member	1447 label Biography information for Andrew Rosindell

1680755

registered interest
date	09/01/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, if he will make an assessment of the potential merits of harm reduction units for the use of drug taking in a safe environment.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	8775
answer	answer is ministerial correction date of answer 16/01/2024 answer text <p>The term ‘harm reduction units for the use of drug taking in a safe environment’ refers to what are often more commonly known as Drug Consumption Rooms (DCRs).</p><p>The Government does not support DCRs. We have been clear that we have concerns about the potential for these facilities to appear to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales. While we remain open to considering any new evidence, the evidence available to date has informed the current policy position.</p> answering member constituency Croydon South answering member printed Chris Philp question first answered 16/01/2024 17:42:26 answering member 4503 label Biography information for Chris Philp
tabling member	4471 label Biography information for Rachael Maskell

1678712

registered interest
date	18/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 14 December (HL767), on what basis the Advisory Council for the Misuse of Drugs report Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016, sent to the Home Secretary in December 2016, was shared "in confidence"; and who took the decision to waive any such confidentiality in relation to the part of the report that has been made public.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1278
answer	answer is ministerial correction date of answer 20/12/2023 answer text <p>As set out by the response to Written Answer HL767, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled “Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016” “in confidence”. The document was not intended for publication and there are no plans to publish it. The portion that has been made public was made public under the terms of the Freedom of Information Act 2000 (“FOIA 2000”) and following the decision of the relevant tribunal (case reference EA/2021/0301).</p><p> </p><p>The portion released under the FOIA 2000 recommended a review of the Working Protocol between the ACMD and the Home Office to take into account the functions of the ACMD under the Psychoactive Substances Act 2016 (“the 2016 Act”). The Working Protocol has not been revised since 2011 and is available at the following link: <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7C0f3b5e5094924fd41a1f08dc007d513b%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638385785729643796%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=XnT9RCvi7TX1aQJ07uHM7aufQZsu5b94e9Vwc0EZ1H4%3D&amp;reserved=0" target="_blank">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)</a></p><p> </p><p>The Government intends to undertake a review in due course and if this results in a revised Working Protocol, the revised version will be published on gov.uk.</p> answering member printed Lord Sharpe of Epsom grouped question UIN HL1279 HL1280 question first answered 20/12/2023 16:45:20 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1678713

registered interest
date	18/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 14 December (HL767), what steps they have taken to ensure that parliamentarians are properly informed about the issues raised in the Advisory Council for the Misuse of Drugs report Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016, sent to the Home Secretary in December 2016.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1279
answer	answer is ministerial correction date of answer 20/12/2023 answer text <p>As set out by the response to Written Answer HL767, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled “Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016” “in confidence”. The document was not intended for publication and there are no plans to publish it. The portion that has been made public was made public under the terms of the Freedom of Information Act 2000 (“FOIA 2000”) and following the decision of the relevant tribunal (case reference EA/2021/0301).</p><p> </p><p>The portion released under the FOIA 2000 recommended a review of the Working Protocol between the ACMD and the Home Office to take into account the functions of the ACMD under the Psychoactive Substances Act 2016 (“the 2016 Act”). The Working Protocol has not been revised since 2011 and is available at the following link: <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7C0f3b5e5094924fd41a1f08dc007d513b%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638385785729643796%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=XnT9RCvi7TX1aQJ07uHM7aufQZsu5b94e9Vwc0EZ1H4%3D&amp;reserved=0" target="_blank">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)</a></p><p> </p><p>The Government intends to undertake a review in due course and if this results in a revised Working Protocol, the revised version will be published on gov.uk.</p> answering member printed Lord Sharpe of Epsom grouped question UIN HL1278 HL1280 question first answered 20/12/2023 16:45:20 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1678715

registered interest
date	18/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they made of the effectiveness of overdose prevention centres in reducing death and other harms caused by drug use to individuals and society; and why they do not support pilot overdose prevention centres.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1281
answer	answer is ministerial correction date of answer 11/01/2024 answer text <p>The Government does not support drug consumption rooms. We have been clear that we have concerns about the potential for these facilities to appear to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales.</p><p> </p><p>We are aware of previous international studies of DCRs, sometimes referred to as overdose prevention centres, although there is usually little or no focus on how far DCRs reduce illicit drug use by those using DCRs, or whether they result in reductions in overall drug use. Methodological and geographical differences as well as the small number of cities where DCRs operate makes it difficult to draw firm conclusions at this stage. In addition, the impact of DCRs in isolation is hard to measure as a range of other support and interventions such as needle and syringe exchange programmes are often provided within a DCR.</p><p> </p> answering member printed Lord Sharpe of Epsom question first answered 11/01/2024 14:21:25 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1675121

registered interest
date	04/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, how much funding was provided to Blue Blight Commercial as part of Operation Safeguard.
tabling member constituency	Brentford and Isleworth
tabling member printed	Ruth Cadbury
uin	5061
answer	answer is ministerial correction date of answer 12/12/2023 answer text <p>BlueLight Commercial is company that is owned by the policing sector. It was set up to provide commercial expertise and assistance to policing and assist forces in identifying and making efficiency savings.</p><p>The Government have not provided specific funding to BlueLight Commercial for their work on Operation Safeguard. BlueLight Commercial have direct arrangements with the policing sector to cover administrative costs they have incurred for the work they have delivered.</p> answering member constituency Croydon South answering member printed Chris Philp question first answered 12/12/2023 12:48:43 answering member 4503 label Biography information for Chris Philp
tabling member	4389 label Biography information for Ruth Cadbury